ABERRANT CD8 ANTIGEN EXPRESSION IN A PATIENT WITH B-CHRONIC LYMPHOCYTIC-LEUKEMIA SHOWING UNUSUAL DISEASE PROGRESSION

被引:18
作者
GHOSH, K [1 ]
SIVAKUMARAN, M [1 ]
WOOD, JK [1 ]
机构
[1] LEICESTER ROYAL INFIRM,DEPT HAEMATOL,LEICESTER LE1 5WW,ENGLAND
关键词
D O I
10.1111/j.1365-2141.1993.tb08673.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Co-expression of T cell antigens in B-CLL has been well recognized. The commonest T cell antigen known to be expressed in B-CLL is CD5, and recent reports suggest that CD5 expression is associated with good prognosis. Expression of CD8 antigen, however, is much less common with uncertain prognostic significance. We report a case of B-CLL with aberrant CD8 expression, who had unusual disease progression with a fatal outcome.
引用
收藏
页码:205 / 206
页数:2
相关论文
共 4 条
[1]   PROPOSALS FOR THE CLASSIFICATION OF CHRONIC (MATURE) B-LYMPHOID AND T-LYMPHOID LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (06) :567-584
[2]   IMMUNOPHENOTYPIC SUBCLASSIFICATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) [J].
KUREC, AS ;
THREATTE, GA ;
GOTTLIEB, AJ ;
SMITH, JR ;
ANDERSON, J ;
DAVEY, FR .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (01) :45-51
[3]  
LUST JA, 1989, AM J MED, V87, P214
[4]   B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - PROGNOSTIC VALUE OF THE IMMUNOPHENOTYPE AND THE CLINICO-HEMATOLOGICAL FEATURES [J].
ORFAO, A ;
GONZALEZ, M ;
MIGUEL, JFS ;
RIOS, A ;
CANIZO, MC ;
HERNANDEZ, J ;
MARICATO, ML ;
BORRASCA, AL .
AMERICAN JOURNAL OF HEMATOLOGY, 1989, 31 (01) :26-31